Show simple item record

dc.creatorde Moraes Fracasso,Bianca
dc.creatorBarcelos Morais,Maite
dc.creatorGomez,Rosane
dc.creatorHilbig,Arlete
dc.creatorIraci Rabito,Estela
dc.date2013-06-01
dc.date.accessioned2020-08-05T02:56:54Z
dc.date.available2020-08-05T02:56:54Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-75182013000200001
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/149838
dc.descriptionLevodopa is the principal pharmacological treatment for Parkinson's disease (PD); however the protein content in diet may compromise its effectiveness. The aim of this study was to investigate the relationship of protein intake and the use of levodopa in ambulatory patients with PD. Thirty four PD patients were assessed for protein intake, evaluating the relation energy-protein intake by means of a register. An intake of 1762 kcal/day, 70.9 g of protein/day equivalent to 16.6% of the total energy intake as protein at a level of 1.1 g/kg bw/day. Of all patients, 47.1% took their medications with meals. We conclude that the studied patients consume more protein in their diet than those recommended for PD, with half the sample taking the medications with meals, which may affect the treatment.
dc.formattext/html
dc.languageen
dc.publisherSociedad Chilena de Nutrición, Bromatología y Toxicología
dc.relation10.4067/S0717-75182013000200001
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceRevista chilena de nutrición v.40 n.2 2013
dc.subjectneurodegenerative diseases
dc.subjecthigh protein diet
dc.subjectdrug-food interactions
dc.subjectcarbidopa
dc.titleProtein intake and the use of levodopa in patients with Parkinson's disease


This item appears in the following Collection(s)

Show simple item record